Skip to main content
OpenTrials

Clinical trial condition

Solid Tumors

Explore clinical trials studying Solid Tumors. Study availability and eligibility vary by location and protocol.

587 public trials 82 recruiting studies
Refine in advanced search Browse all conditions

Solid Tumors trial results

Recruiting

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

NCT07415031

Conditions
Solid Tumors
Locations
  • Local Institution - 0005 Phoenix, Arizona, United States
  • Southern California Permanente Medical Group Bellflower, California, United States
  • Local Institution - 0082 Long Beach, California, United States
  • Local Institution - 0003 Newark, Delaware, United States
View all 100 locations
View Trial Details
Recruiting

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

NCT03486873

Conditions
Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +4 more
Locations
  • Arizona Cancer Center at UMC North ( Site 0018) Tucson, Arizona, United States
  • Comprehensive Blood & Cancer Center [Bakersfield, CA] ( Site 0054) Bakersfield, California, United States
  • California Cancer Associates for Research & Excellence ( Site 0016) Fresno, California, United States
  • Providence Medical Foundation ( Site 0087) Fullerton, California, United States
View all 776 locations
View Trial Details
Recruiting

A Study of GEN1106 in Participants With Solid Tumors

NCT07416123

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +4 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • START New York Long Island LLC Lake Success, New York, United States
  • Carolina Urologic Research Center Myrtle Beach, South Carolina, United States
  • South Texas Accelerated Research Therapeutics San Antonio, Texas, United States
View Trial Details
Recruiting

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

NCT07522073

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Investigative Site US058 Birmingham, Alabama, United States
  • Investigative Site US016 Anchorage, Alaska, United States
  • Investigative Site US026 Chandler, Arizona, United States
  • Investigative Site US045 Tucson, Arizona, United States
View all 219 locations
View Trial Details
Recruiting

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

NCT07195916

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +29 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of California San Diego Medical Center, Moores Cancer Center La Jolla, California, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • The University of Nebraska Medical Center Omaha, Nebraska, United States
View all 22 locations
View Trial Details
Recruiting

A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

NCT05471856

Conditions
Solid Tumors
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • John Theurer Cancer Center Hackensack, New Jersey, United States
  • National Cancer Center Hospital East Chiba, Kashiwa, Japan
View all 13 locations
View Trial Details
Recruiting

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

NCT07492680

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +22 more
Locations
  • Local Institution - 0096 San Francisco, California, United States
  • Local Institution - 0182 Aurora, Colorado, United States
  • Local Institution - 0178 Atlanta, Georgia, United States
  • Local Institution - 0124 Boston, Massachusetts, United States
View all 57 locations
View Trial Details

Related conditions